Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

Detalles Bibliográficos
Autores principales: Pestinger, Valerie, Smith, Matthew, Sillo, Toju, Findlay, John M., Laes, Jean‑Francois, Martin, Gerald, Middleton, Gary, Taniere, Phillipe, Beggs, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363732/
https://www.ncbi.nlm.nih.gov/pubmed/32572786
http://dx.doi.org/10.1007/s40291-020-00479-2
_version_ 1783559695602024448
author Pestinger, Valerie
Smith, Matthew
Sillo, Toju
Findlay, John M.
Laes, Jean‑Francois
Martin, Gerald
Middleton, Gary
Taniere, Phillipe
Beggs, Andrew D.
author_facet Pestinger, Valerie
Smith, Matthew
Sillo, Toju
Findlay, John M.
Laes, Jean‑Francois
Martin, Gerald
Middleton, Gary
Taniere, Phillipe
Beggs, Andrew D.
author_sort Pestinger, Valerie
collection PubMed
description
format Online
Article
Text
id pubmed-7363732
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73637322020-07-20 Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants Pestinger, Valerie Smith, Matthew Sillo, Toju Findlay, John M. Laes, Jean‑Francois Martin, Gerald Middleton, Gary Taniere, Phillipe Beggs, Andrew D. Mol Diagn Ther Correction Springer International Publishing 2020-06-22 2020 /pmc/articles/PMC7363732/ /pubmed/32572786 http://dx.doi.org/10.1007/s40291-020-00479-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Pestinger, Valerie
Smith, Matthew
Sillo, Toju
Findlay, John M.
Laes, Jean‑Francois
Martin, Gerald
Middleton, Gary
Taniere, Phillipe
Beggs, Andrew D.
Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
title Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
title_full Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
title_fullStr Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
title_full_unstemmed Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
title_short Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
title_sort correction to: use of an integrated pan-cancer oncology enrichment next-generation sequencing assay to measure tumour mutational burden and detect clinically actionable variants
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363732/
https://www.ncbi.nlm.nih.gov/pubmed/32572786
http://dx.doi.org/10.1007/s40291-020-00479-2
work_keys_str_mv AT pestingervalerie correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT smithmatthew correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT sillotoju correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT findlayjohnm correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT laesjeanfrancois correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT martingerald correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT middletongary correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT tanierephillipe correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants
AT beggsandrewd correctiontouseofanintegratedpancanceroncologyenrichmentnextgenerationsequencingassaytomeasuretumourmutationalburdenanddetectclinicallyactionablevariants

Ejemplares similares